A group of researchers at Qatar Foundation led by Dr. Lotfi Chouchane from Weill Cornell Medicine—Qatar (WCM-Q) have reported the first landscape of cancer germline variation in the Middle East that has been published online ...
Feb 10, 2022
0
3
Flow cytometry is a powerful and complex technology used to count, sort or measure characteristics of cells and to detect biomarkers. It's also widely used in research, as well as in clinical studies and diagnosis of disorders ...
Feb 9, 2022
0
72
Cancer metastases, the main cause of cancer-related mortality, are sometimes triggered by successful chemotherapy. A research group at the Rappaport Faculty of Medicine analyzed this phenomenon and demonstrated ways of intervening ...
Feb 8, 2022
0
26
A new study by researchers at Yale Cancer Center shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing. The discovery is an early step in finding new therapeutics for triple-negative ...
Feb 3, 2022
0
137
Researchers at Karolinska Institutet and the University of Gothenburg have found another piece of the puzzle in the treatment of the childhood cancer neuroblastoma. A new case report, published in JCO Precision Oncology, ...
Feb 2, 2022
0
10
A genome study undertaken by Johns Hopkins Kimmel Cancer Center researchers to look for variants in a gene considered a fundamental building block for microscopic structures that synthesize proteins took a surprising twist.
Feb 2, 2022
0
75
T-cell receptors (TCRs), found on the surface of antigen specific T-lymphocytes, are incredibly diverse proteins that are programmed to recognize foreign bodies or "antigens," and alert T-cells about their presence in our ...
Jan 19, 2022
0
4
In the United States alone, about 3.3 million people are diagnosed with basal and squamous cell cancers (skin cancers) per year. Skin cancer is still detected using visual examination, a method of limited reliability for ...
Dec 22, 2021
0
10
A unique collection of tissue samples donated by people with chronic myeloid leukemia was the driving force behind the discovery of a potentially major new treatment approach for drug-resistant leukemia. As published this ...
Dec 21, 2021
0
60
Precision therapies targeting melanoma and other cancers have improved patient survival, but tumors often stop responding to drugs, and recent studies point to changes in DNA—both inside and outside chromosomes—as a driving ...
Dec 20, 2021
0
68
